124 related articles for article (PubMed ID: 8241512)
1. Regulation of human neutrophil aggregation: comparable latent times, activator sensitivities, and exponential decay in aggregability for FMLP, platelet-activating factor, and leukotriene B4.
Rochon YP; Frojmovic MM
Blood; 1993 Dec; 82(11):3460-8. PubMed ID: 8241512
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
[TBL] [Abstract][Full Text] [Related]
3. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
Zhou W; Javors MA; Olson MS
Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils.
Rossi AG; McMillan RM; MacIntyre DE
Agents Actions; 1988 Jul; 24(3-4):272-82. PubMed ID: 2845744
[TBL] [Abstract][Full Text] [Related]
5. Calcium ionophore potentiates chemotactic peptide and platelet activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
Tanizawa H; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):45-9. PubMed ID: 2169061
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4.
Gay JC; Beckman JK; Brash AR; Oates JA; Lukens JN
Blood; 1984 Oct; 64(4):780-5. PubMed ID: 6089934
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils.
Lerner R; Lindström P; Palmblad J
Biochem Biophys Res Commun; 1988 Jun; 153(2):805-10. PubMed ID: 2838025
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
[TBL] [Abstract][Full Text] [Related]
9. Chemotactic peptide down-regulation of calcium mobilization induced by platelet-activating factor and by leukotriene B4 in human neutrophils is uncovered by protein phosphatase inhibitors.
Montero M; Garcia-Sancho J; Alverez J
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):559-66. PubMed ID: 7980418
[TBL] [Abstract][Full Text] [Related]
10. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4.
Dewald B; Baggiolini M
Biochem Biophys Res Commun; 1985 Apr; 128(1):297-304. PubMed ID: 2985075
[TBL] [Abstract][Full Text] [Related]
11. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of propranolol on responses to receptor-dependent and receptor-independent stimuli in human neutrophils.
Gay JC; Murray JJ
Biochim Biophys Acta; 1991 Nov; 1095(3):236-42. PubMed ID: 1659906
[TBL] [Abstract][Full Text] [Related]
13. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
Beckman JK; Gay JC; Brash AR; Lukens JN; Oates JA
Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
Ford-Hutchinson AW
Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
17. Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
Tanizawa H; Tai HH
Biochem Pharmacol; 1989 Aug; 38(15):2559-63. PubMed ID: 2547385
[TBL] [Abstract][Full Text] [Related]
18. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
Rosenthal MD; Franson RC
J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290
[TBL] [Abstract][Full Text] [Related]
19. Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients.
Yamauchi A; Degawa-Yamauchi M; Kuribayashi F; Kanegasaki S; Tsuchiya T
J Immunol Methods; 2014 Feb; 404():59-70. PubMed ID: 24370750
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.
McIntyre TM; Reinhold SL; Prescott SM; Zimmerman GA
J Biol Chem; 1987 Nov; 262(32):15370-6. PubMed ID: 2824456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
